英
美
-
(=nonsmall-cell lung cancer) 非小細胞(型)肺癌
-
NSCLC的用法和樣例:
例句
- Now it is mainly used as second-line or third-line therapy for NSCLC in many countries.
目前它主要用於終末期非小細胞肺癌的二線和三線治療。
- Our five-gene signature is closely associated with relapse-free and overall survival among patients with NSCLC.
我們的五個基因標記與非小細胞肺癌患者的無複發及總生存率密切相關。
以上內容獨家創作,受著作權保護,侵權必究